CVS Health (CVS) has shown modest growth over the past five years, with a $100 investment now valued at approximately $108.11. While this represents a gain, it significantly lags behind the S&P 500’s performance, which would have turned the same investment into about $171.46, reflecting an average annual return of 11%. This stark contrast highlights the opportunity cost of investing in CVS compared to broader market indices.
Despite CVS’s recent revenue growth of 8.2% in Q4 and 7.8% for the full year, the company faces challenges, particularly in its Aetna business related to Medicare Advantage plans, which are not expected to see significant rate increases. Additionally, rising costs are squeezing profit margins, raising questions about the sustainability of its growth trajectory.
For investors considering CVS, the stock offers a solid dividend yield of 3.8%. However, market professionals should weigh this against faster-growing alternatives and dividend stocks that may provide better overall returns.
Source: fool.com